Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 17, 2026

Fluor Reports Fourth Quarter and Full Year 2025 Results

View original at finance.yahoo.com
Fluor Reports Fourth Quarter and Full Year 2025 Results Full year 2025 share repurchases of $754 million; $1.4 billion planned for 2026 Full year new awards of $12.0 billion; 87% reimbursable Ending Backlog of $25.5 billion; 81% reimbursable Received $1.35 billion in Q1 2026 for NuScale share sales IRVING, Texas, Febru…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The monetization of Fluor's NuScale investment is progressing well and the company is returning significant value to shareholders.

    80% confidence
  • Energy Solutions awards in 2025 were primarily related to higher margin engineering services work that will enable larger EPC awards in the next two years.

    80% confidence
  • Fluor anticipates full monetization of its NuScale investment by end of Q2 2026.

    80% confidence
  • Adjusted EBITDA guidance for 2026 is $525 million to $585 million.

    80% confidence
  • Fluor is not providing forward-looking guidance for U.S. GAAP net earnings or EPS for 2026.

    80% confidence
  • Fluor returned substantial capital in 2025 while maintaining a strong liquidity position.

    80% confidence
  • Growing confidence in capturing significant EPC awards in 2026 and into 2027, supported by an improving capital spending environment and increasing client commitments.

    80% confidence
  • Continued monetization of the NuScale investment has enhanced financial flexibility to drive organic growth, M&A opportunities, and continued share repurchases.

    80% confidence
  • Fluor's diversified portfolio and strong capital position will support delivery of its growth strategy.

    80% confidence
  • Fluor's capital allocation strategy is directly aligned with its growth priorities and commitment to deliver shareholder value.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com